Your shopping cart is currently empty

MS-L6 is an inhibitor of the mitochondrial respiratory complex I (ETC-I) with uncoupling properties. This product blocks oxidative phosphorylation (OXPHOS) by inhibiting NADH oxidation and exerting uncoupling effects. MS-L6 reduces mitochondrial membrane potential, inhibits ATP production, and induces mitochondrial dysfunction and apoptosis in tumor cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $41 | - | In Stock | |
| 5 mg | $78 | - | In Stock | |
| 10 mg | $124 | - | In Stock | |
| 25 mg | $249 | - | In Stock | |
| 50 mg | $398 | - | In Stock | |
| 100 mg | $630 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $95 | - | In Stock |
| Description | MS-L6 is an inhibitor of the mitochondrial respiratory complex I (ETC-I) with uncoupling properties. This product blocks oxidative phosphorylation (OXPHOS) by inhibiting NADH oxidation and exerting uncoupling effects. MS-L6 reduces mitochondrial membrane potential, inhibits ATP production, and induces mitochondrial dysfunction and apoptosis in tumor cells. |
| In vitro | In multiple cancer cell lines, MS-L6 dose-dependently reduces oxygen consumption rate (OCR) and ATP levels, triggering mitochondrial membrane potential loss and cytochrome c release to activate caspase-3 and induce apoptosis [1]. |
| In vivo | In pharmacological studies using tumor xenograft mouse models, systemic administration of MS-L6 (at doses such as 10-20 mg/kg) leads to a significant reduction in tumor volume and weight; the treatment results in decreased intratumoral ATP concentrations and increased expression of apoptotic markers, demonstrating effective suppression of tumor progression through mitochondrial metabolic disruption [1]. |
| Synonyms | NSC34338, Agn-PC-0N3ahi |
| Molecular Weight | 548.4 |
| Formula | C20H28Br2N4S2 |
| Cas No. | 63498-32-8 |
| Smiles | N=C(NC1=CC=CC=C1)SCCCCCCSC(NC2=CC=CC=C2)=N.Br.Br |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 3.00 mg/mL (5.47 mM), Sonication is recommended. DMSO: 100.00 mg/mL (182.35 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.